Henry Gosebruch
Chief Executive Officer bei NEUMORA THERAPEUTICS, INC.
Vermögen: 9 Mio $ am 31.12.2023
Profil
Henry O.
Gosebruch is currently the President, Chief Executive Officer & Director at Neumora Therapeutics, Inc. and a Director at ACELYRIN, Inc. Previously, he served as an Independent Director at Aptinyx, Inc. from 2019 to 2023.
Prior to that, he was the Chief Strategy Officer & Executive Vice President at AbbVie, Inc. from 2015 to 2023 and Co-Head of Mergers & Acquisitions North America at JPMorgan Securities LLC from 1995 to 2015.
He received his undergraduate degree from The Wharton School of the University of Pennsylvania in 1995.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
14.02.2024 | 604 793 ( 0,38% ) | 8 Mio $ | 31.03.2024 | |
ACELYRIN, INC.
0,05% | 09.05.2023 | 50 000 ( 0,05% ) | 337 500 $ | 31.03.2024 |
APTINYX INC
0,18% | 24.04.2023 | 125 000 ( 0,18% ) | 12 000 $ | 31.12.2023 |
Aktive Positionen von Henry Gosebruch
Unternehmen | Position | Beginn |
---|---|---|
ACELYRIN, INC. | Director/Board Member | 29.03.2023 |
NEUMORA THERAPEUTICS, INC. | Chief Executive Officer | 18.07.2023 |
Ehemalige bekannte Positionen von Henry Gosebruch
Unternehmen | Position | Ende |
---|---|---|
APTINYX | Director/Board Member | 04.05.2023 |
ABBVIE INC. | Corporate Officer/Principal | 01.02.2023 |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01.12.2015 |
Ausbildung von Henry Gosebruch
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
ABBVIE INC. | Health Technology |
APTINYX | Health Technology |
ACELYRIN, INC. | Health Technology |
NEUMORA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |